Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
22197 | 333 | 24.8 | 62% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
1825 | 5671 | HUMAN ENDOGENOUS RETROVIRUS//ADAR//ENDOGENOUS RETROVIRUS |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | RT ASSAY | Author keyword | 9 | 83% | 2% | 5 |
2 | VIRUS FILTRATION | Author keyword | 8 | 46% | 4% | 13 |
3 | VIRAL CLEARANCE | Author keyword | 7 | 24% | 7% | 24 |
4 | VIRUS CLEARANCE | Author keyword | 4 | 29% | 4% | 13 |
5 | PLANOVA | Address | 3 | 50% | 2% | 5 |
6 | XMULV | Author keyword | 3 | 100% | 1% | 3 |
7 | VIRUS REMOVAL FILTER | Author keyword | 3 | 60% | 1% | 3 |
8 | XENOTROPIC MURINE LEUKEMIA VIRUS | Author keyword | 3 | 60% | 1% | 3 |
9 | VIRAL SAFETY | Author keyword | 2 | 17% | 4% | 12 |
10 | FILTER FOULING | Author keyword | 2 | 67% | 1% | 2 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | RT ASSAY | 9 | 83% | 2% | 5 | Search RT+ASSAY | Search RT+ASSAY |
2 | VIRUS FILTRATION | 8 | 46% | 4% | 13 | Search VIRUS+FILTRATION | Search VIRUS+FILTRATION |
3 | VIRAL CLEARANCE | 7 | 24% | 7% | 24 | Search VIRAL+CLEARANCE | Search VIRAL+CLEARANCE |
4 | VIRUS CLEARANCE | 4 | 29% | 4% | 13 | Search VIRUS+CLEARANCE | Search VIRUS+CLEARANCE |
5 | XMULV | 3 | 100% | 1% | 3 | Search XMULV | Search XMULV |
6 | VIRUS REMOVAL FILTER | 3 | 60% | 1% | 3 | Search VIRUS+REMOVAL+FILTER | Search VIRUS+REMOVAL+FILTER |
7 | XENOTROPIC MURINE LEUKEMIA VIRUS | 3 | 60% | 1% | 3 | Search XENOTROPIC+MURINE+LEUKEMIA+VIRUS | Search XENOTROPIC+MURINE+LEUKEMIA+VIRUS |
8 | VIRAL SAFETY | 2 | 17% | 4% | 12 | Search VIRAL+SAFETY | Search VIRAL+SAFETY |
9 | FILTER FOULING | 2 | 67% | 1% | 2 | Search FILTER+FOULING | Search FILTER+FOULING |
10 | PRODUCT ENHANCED REVERSE TRANSCRIPTASE ASSAY | 2 | 50% | 1% | 3 | Search PRODUCT+ENHANCED+REVERSE+TRANSCRIPTASE+ASSAY | Search PRODUCT+ENHANCED+REVERSE+TRANSCRIPTASE+ASSAY |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | MONITOR RETROVIRUS | 15 | 88% | 2% | 7 |
2 | MAB CELL CULTURE | 9 | 83% | 2% | 5 |
3 | SIZE EXCLUSION REMOVAL | 9 | 83% | 2% | 5 |
4 | PHARMACEUTICAL PROTEIN PURIFICATION | 8 | 100% | 2% | 5 |
5 | FAST FLOW CHROMATOGRAPHY | 6 | 80% | 1% | 4 |
6 | REVERSE TRANSCRIPTASE ASSAY | 3 | 27% | 3% | 11 |
7 | CELL LINE YMNU | 3 | 100% | 1% | 3 |
8 | INVIVO INVITRO ASSAY | 3 | 100% | 1% | 3 |
9 | PARVOVIRUS FILTER | 3 | 100% | 1% | 3 |
10 | MICROPOROUS MEMBRANE FILTER | 3 | 60% | 1% | 3 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references |
% act. ref. to same field |
---|---|---|---|---|
Chemical modification of gene silencing oligonucleotides for drug discovery and development | 2005 | 44 | 42 | 17% |
Nanofiltration of plasma-derived biopharmaceutical products | 2003 | 92 | 50 | 8% |
Downstream processing in the biotechnology industry | 2002 | 10 | 15 | 20% |
Biosafety and product release testing issues relevant to replication-competent oncolytic viruses | 2002 | 7 | 13 | 23% |
The clearance of viruses and transmissible spongiform encephalopathy agents from biologicals | 2005 | 17 | 32 | 16% |
Validation of biopharmaceutical purification processes for virus clearance evaluation | 2002 | 13 | 16 | 13% |
Quality by Design applications in biosimilar pharmaceutical products | 2008 | 5 | 10 | 10% |
Nonisotopic assays of viral polymerases and related proteins | 1996 | 4 | 38 | 13% |
IMMUNOLOGICAL CHARACTERIZATION OF REVERSE-TRANSCRIPTASE FROM HUMAN-TUMOR TISSUES | 1983 | 2 | 4 | 75% |
MOLECULAR RECOGNITION - A UNIVERSAL MOLECULAR SCIENCE | 1991 | 4 | 6 | 17% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | PLANOVA | 3 | 50% | 1.5% | 5 |
2 | OFF BIOTECHNOL PROD | 2 | 11% | 3.9% | 13 |
3 | BIOPROC TECHNOL DEV | 1 | 100% | 0.6% | 2 |
4 | LILLY CORP DC3941 | 1 | 100% | 0.6% | 2 |
5 | VIRAL CLEARANCE CELL LINE DEV | 1 | 100% | 0.6% | 2 |
6 | LATE STAGE PURIFICAT | 1 | 30% | 0.9% | 3 |
7 | ANIM CELL BANK | 1 | 50% | 0.3% | 1 |
8 | BIOPHARMACEUT SAFETY VALIDAT | 1 | 50% | 0.3% | 1 |
9 | BIOPURIFICAT DEV | 1 | 50% | 0.3% | 1 |
10 | ERYTHROPOIETIN PROD | 1 | 50% | 0.3% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000121017 | CHAIR BIOPROC ENGN//VACCINE PRODUCTION//RESIDUAL DNA |
2 | 0.0000118223 | AMOTOSALEN//PATHOGEN INACTIVATION//SOLVENT DETERGENT |
3 | 0.0000106263 | HYDROPHOBIC CHARGE INDUCTION CHROMATOGRAPHY//HYDROPHOBIC INTERACTION CHROMATOGRAPHY//DISPLACEMENT CHROMATOGRAPHY |
4 | 0.0000095407 | VL30//INTRACISTERNAL A PARTICLE//EARLY TRANSPOSON |
5 | 0.0000091481 | XMRV//XENOTROPIC MURINE LEUKEMIA VIRUS RELATED VIRUS//XENOTROPIC MURINE LEUKEMIA VIRUS RELATED VIRUS XMRV |
6 | 0.0000084125 | CANCERPHOBIA//MEDICINE IN LITERATURE//BOVINE POLYOMAVIRUS |
7 | 0.0000069557 | ENDOTOXIN REMOVAL//LPS REMOVAL//POCKET CALCULATOR |
8 | 0.0000064339 | PORCINE ENDOGENOUS RETROVIRUSES//PERV//PORCINE CYTOMEGALOVIRUS |
9 | 0.0000060454 | RALSTONIA PICKETTII//BREVUNDIMONAS DIMINUTA//FILTER VALIDATION |
10 | 0.0000058485 | NNRTIS//REVERSE TRANSCRIPTASE//HIV 1 REVERSE TRANSCRIPTASE |